Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-4-3
pubmed:abstractText
To establish whether chronic opiate exposure might impair brain dopaminergic or serotonergic function in humans, we assessed biochemical indices of monoaminergic neurotransmitter activity and integrity in post mortem striatum of nine chronic heroin users and 14 control subjects. Striatal levels of the vesicular monoamine transporter were normal, suggesting that the density of dopamine nerve terminals is not reduced in heroin users. In nucleus accumbens, levels of tyrosine hydroxylase protein (-25%) and those of the dopamine metabolite homovanillic acid (-33%) were reduced significantly together with a trend for decreased dopamine (-32%) concentration. These changes could reflect either a compensatory downregulation of dopamine biosynthesis in response to prolonged dopaminergic stimulation caused by heroin, or reduced axoplasmic transport of tyrosine hydroxylase. Striatal levels of serotonin were either normal or elevated whereas concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid were decreased by 27-38%. Our data suggest that chronic heroin exposure might produce a modest reduction in dopaminergic and serotonergic activity that could affect motivational state and impulse control, respectively.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Dopa Decarboxylase, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport..., http://linkedlifedata.com/resource/pubmed/chemical/Homovanillic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine 3-Monooxygenase, http://linkedlifedata.com/resource/pubmed/chemical/Vesicular Biogenic Amine Transport..., http://linkedlifedata.com/resource/pubmed/chemical/Vesicular Monoamine Transport...
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0893-133X
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
561-7
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed-meshheading:11282256-Adult, pubmed-meshheading:11282256-Biological Markers, pubmed-meshheading:11282256-Carrier Proteins, pubmed-meshheading:11282256-Dopa Decarboxylase, pubmed-meshheading:11282256-Dopamine, pubmed-meshheading:11282256-Dopamine Plasma Membrane Transport Proteins, pubmed-meshheading:11282256-Female, pubmed-meshheading:11282256-Heroin Dependence, pubmed-meshheading:11282256-Homovanillic Acid, pubmed-meshheading:11282256-Humans, pubmed-meshheading:11282256-Hydroxyindoleacetic Acid, pubmed-meshheading:11282256-Male, pubmed-meshheading:11282256-Membrane Glycoproteins, pubmed-meshheading:11282256-Membrane Transport Proteins, pubmed-meshheading:11282256-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:11282256-Neostriatum, pubmed-meshheading:11282256-Nerve Tissue Proteins, pubmed-meshheading:11282256-Neurons, pubmed-meshheading:11282256-Neuropeptides, pubmed-meshheading:11282256-Serotonin, pubmed-meshheading:11282256-Tyrosine 3-Monooxygenase, pubmed-meshheading:11282256-Vesicular Biogenic Amine Transport Proteins, pubmed-meshheading:11282256-Vesicular Monoamine Transport Proteins
pubmed:year
2001
pubmed:articleTitle
Striatal dopaminergic and serotonergic markers in human heroin users.
pubmed:affiliation
Human Neurochemical Pathology Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Stephen_Kish@CAMH.net
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.